Kreitzer Anatol bought MPLT
October 27, 2025 · Form 4 insider transaction
Kreitzer Anatol bought 146,052 shares of MapLight Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
146,052
Price
$0.00
Total value
N/A
InsiderKreitzer Anatol
RoleOfficer
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 27, 2025
Filing dateOctober 28, 2025
Shares owned after146,052
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.